<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04801069</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02878-31</org_study_id>
    <nct_id>NCT04801069</nct_id>
  </id_info>
  <brief_title>Pilot-Study for SAS Treatment in Acute Cerebral InfarctiOn: the PISTACIO Trial</brief_title>
  <acronym>PISTACIO</acronym>
  <official_title>Pilot-Study for SAS Treatment in Acute Cerebral InfarctiOn: the PISTACIO Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SOS Attaque Cérébrale</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SOS Attaque Cérébrale</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep Apnea Syndrome (SAS) is highly prevalent in acute stroke and it is related to worst&#xD;
      outcome. We aim to assess if SAS treatment, started immediately after acute ischemic stroke,&#xD;
      impacts infarct growing and clinical prognosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct progression</measure>
    <time_frame>7 days</time_frame>
    <description>Ischemic size at 7 days compared to ischemic size at admission on brain MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurological outcome</measure>
    <time_frame>3 months</time_frame>
    <description>modified Rankin score (mRS), from 0 (no disability) to 6 (dead)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological outcome on NIHSS</measure>
    <time_frame>3 months</time_frame>
    <description>National Institute of Health Stroke Scale (NIHSS), from 0 (normal neurological examination) to 42</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Auto-adaptative Servo-Ventilation use</measure>
    <time_frame>7 days</time_frame>
    <description>mean duration per night auto-adaptative servo-ventilation was used during 7 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAS prevalence</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by respiratory polygraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAS severity</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by apnea-hypopnea-index meseared by respiratory polygraphy, mild if AHI is 5-15/h, moderate if AHI is 15-30/h and severe if AHI is &gt; 30/h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central apnea index</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by respiratory polygraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstructive apnea index</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by respiratory polygraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life on SF-12 questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>SF-12 (Short Form Survey 12) questionnaire (not a scale, result is shown as 2 numbers (physical and mental component scores) : if superior to 50, the quality of life is better to the mean quality of life in general population, if less than 50, the quality of life is worse than in the general population)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of sleep on Pittsburgh Sleep Quality Index</measure>
    <time_frame>3 months</time_frame>
    <description>Pittsburgh Sleep Quality Index, from 0 (good quality of sleep) to 21 (bas quality of sleep)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daytime Sleepiness</measure>
    <time_frame>3 months</time_frame>
    <description>Epworth Sleepiness Scale, from 0 (no sleepiness) to 24 (great sleepiness), sleepiness if &gt; 10</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ischemic Stroke</condition>
  <condition>Sleep Apnea Syndromes</condition>
  <arm_group>
    <arm_group_label>Auto-Adaptative Servo-Ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nocturnal Ventilation</intervention_name>
    <description>AirCurve 10CS PaceWave (Resmed)</description>
    <arm_group_label>Auto-Adaptative Servo-Ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  acute ischemic stroke on brain MRI&#xD;
&#xD;
          -  NIHSS 6-22&#xD;
&#xD;
          -  thrombolysis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous SAS&#xD;
&#xD;
          -  Previous stroke&#xD;
&#xD;
          -  Auto-adaptative Servo-Ventilation Contraindication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Meseguer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elena Meseguer, MD</last_name>
    <phone>01 40 25 74 86</phone>
    <email>elena.meseguer@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meseguer</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Elena Meseguer, MD</last_name>
      <phone>0140257490</phone>
      <email>elena.meseguer@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

